Matthew Gdovin, an associate professor in the UTSA Department of Biology, has developed a newly patented method to kill cancer cells. His discovery, described in research published in The Journal of Clinical Oncology, may tremendously help people with inoperable or hard-to-reach tumors, as well as young children stricken with cancer.
Gdovin’s top-tier research involves injecting a chemical compound, nitrobenzaldehyde, into the tumor and allowing it to diffuse into the tissue. He then aims a beam of light at the tissue, causing the cells to become very acidic inside and, essentially, commit suicide. Within two hours, Gdovin estimates up to 95 percent of the targeted cancer cells are dead.
“Even though there are many different types of cancers, the one thing they have in common is their susceptibility to this induced cell suicide,” he said.
Gdovin tested his method against triple negative breast cancer, one of the most aggressive types of cancer and one of the hardest to treat. The prognosis for triple negative breast cancer is usually very poor. After one treatment in the laboratory, he was able to stop the tumor from growing and double chances of survival in mice.
“All forms of cancer attempt to make cells acidic on the outside as a way to attract the attention of a blood vessel, which attempts to get rid of the acid,” he said. “Instead, the cancer latches onto the blood vessel and uses it to make the tumor larger and larger.”
Chemotherapy treatments target all cells in the body, and certain chemotherapeutics try to keep cancer cells acidic as a way to kill the cancer. This is what causes many cancer patients to lose their hair and become sickly. Gdovin’s method, however, is more precise and can target just the tumor.
In the past two years, he’s developed his photodynamic cancer therapy to the point where it’s non-invasive. It now requires just an injection of the nitrobenzaldehyde fluid followed by a flash of an ultraviolet light to cause the cancer-killing reaction. Gdovin has now begun to test the method on drug-resistant cancer cells to make his therapy as strong as possible. He’s also started to develop a nanoparticle that can be injected into the body to target metastasized cancer cells. The nanoparticle is activated with a wavelength of light that it can pass harmlessly through skin, flesh and bone and still activate the the cancer-killing nanoparticle.
Gdovin hopes that his non-invasive method will help cancer patients with tumors in areas that have proven problematic for surgeons, such as the brain stem, aorta or spine. It could also help people who have received the maximum amount of radiation treatment and can no longer cope with the scarring and pain that goes along with it, or children who are at risk of developing mutations from radiation as they grow older.
“There are so many types of cancer for which the prognosis is very poor,” he said. “We’re thinking outside the box and finding a way to do what for many people is simply impossible.”
The Latest on: Photodynamic cancer therapy
via Google News
The Latest on: Photodynamic cancer therapy
- High Rates of Actinic Keratosis Lesion Recurrence, Even After Clearanceon May 14, 2021 at 8:27 am
The majority of patients who experience clearance of actinic keratosis lesions will experience recurrent lesions.
- Radiofrequency Ablation in Barrett's Esophagus with Dysplasiaon May 12, 2021 at 5:00 pm
with a decreased risk of esophageal cancer in the photodynamic-therapy group. Among patients receiving such therapy, esophageal stricture developed in 36% of the patients, and 69% had a ...
- The Enlightenment of Bladder Cancer Treatmenton May 10, 2021 at 5:00 pm
Of course, before starting to use PDD, a clinic has to afford investments; for example, for the blue-light source and a special optic, that amounts up to approximately €5000.  However, in ...
- The Enlightenment of Bladder Cancer Treatmenton May 8, 2021 at 5:01 pm
Galvanic cautery, the treatment ... cancer.  Table 1. Relevant publications on prospective randomized studies concerning residual tumor rate and recurrence-free survival rate for ...
- Broad Efficacy and Improved Safety Profile of HyBryte™ Presented at Society for Investigative Dermatology Virtual Meetingon May 4, 2021 at 4:41 am
Oral Presentation: Topical hypericin ointment photodynamic therapy is effective and safe ... study was partially funded by the National Cancer Institute via a Phase II SBIR grant (#1R44CA210848 ...
- UI researchers investigating photosensitizing drug to treat soft tissue sarcomason April 30, 2021 at 3:35 pm
Researchers at the University of Iowa are investigating the potential of using photodynamic therapy, a type of cancer treatment that uses high-frequency light and photosensitizing agents, to combat ...
- Highly efficient photodynamic-immunotherapy by combining AIEgen with Poly(I:C)on April 30, 2021 at 7:29 am
Even so, the immunity induced by photodynamic therapy is still difficult to achieve ... revealed that [email protected] NPs simultaneously kill local cancer cells directly and stimulate the immune cells ...
- Strategies to improve photodynamic therapy efficacy by relieving the tumor hypoxia environmenton April 29, 2021 at 8:24 pm
In this review, we summarize the latest progress in the development of strategies to relieve tumor hypoxia for improved PDT efficacy, from the design of novel nonreactive oxygen carriers to reactive ...
- Lumeda Selected as one of the 25 Technology Companies to Watch in the Greater Hartford Areaon April 23, 2021 at 6:53 am
April 23, 2021 /PRNewswire-PRWeb/ -- Lumeda Inc., a medical technology company focused on applying Photodynamic Therapy (PDT) as an adjuvant treatment for lung cancer patients, today announced it ...
- Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular deliveryon April 22, 2021 at 6:30 am
Owing to its unique sensitivity to heat and reactive oxygen species, the mitochondrion is an appropriate target for photothermal and photodynamic treatment for cancer. However, targeted delivery ...
via Bing News